Longval T, Lepretre AC, Ravinet A, Fayard A, et al. Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC. Bone Marrow Transplant 2024;59:893-895.
PMID: 38461290